Pete Newham

531 total citations
7 papers, 412 citations indexed

About

Pete Newham is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Pete Newham has authored 7 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Pete Newham's work include Bone health and treatments (2 papers), Bone and Joint Diseases (2 papers) and Nausea and vomiting management (1 paper). Pete Newham is often cited by papers focused on Bone health and treatments (2 papers), Bone and Joint Diseases (2 papers) and Nausea and vomiting management (1 paper). Pete Newham collaborates with scholars based in United Kingdom, United States and Sweden. Pete Newham's co-authors include M. Paola Castaldi, Helen Boyd, Muireann Coen, Kévin Moreau, Clay W. Scott, Fiona Pachl, Göran Dahl, Andrew X. Zhang, David J. Hunter and Rose A. Maciewicz and has published in prestigious journals such as British Journal of Pharmacology, Toxicology and Applied Pharmacology and Osteoarthritis and Cartilage.

In The Last Decade

Pete Newham

7 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pete Newham United Kingdom	5	210	143	103	79	71	7	412
Zenong Yuan China	10	171 0.8×	52 0.4×	34 0.3×	27 0.3×	34 0.5×	21	317
Yu Yamashita Japan	7	187 0.9×	55 0.4×	66 0.6×	19 0.2×	13 0.2×	10	274
Ruth Wills United States	7	119 0.6×	48 0.3×	156 1.5×	35 0.4×	13 0.2×	7	296
Emily G. Atkinson United States	9	224 1.1×	17 0.1×	76 0.7×	63 0.8×	18 0.3×	18	326
Hiroomi Tateishi Japan	9	89 0.4×	155 1.1×	49 0.5×	17 0.2×	49 0.7×	14	330
Yoshiya Tomimori Japan	9	269 1.3×	30 0.2×	185 1.8×	44 0.6×	22 0.3×	10	393
Megan M. Hanlon Ireland	10	132 0.6×	141 1.0×	70 0.7×	10 0.1×	17 0.2×	14	377
Yasuyuki Kaneta Japan	8	174 0.8×	25 0.2×	75 0.7×	19 0.2×	14 0.2×	10	290
Marielle Auberval France	8	137 0.7×	43 0.3×	50 0.5×	17 0.2×	18 0.3×	11	334
Michele McElvain United States	9	175 0.8×	11 0.1×	110 1.1×	18 0.2×	24 0.3×	15	345

Countries citing papers authored by Pete Newham

Since Specialization

Citations

This map shows the geographic impact of Pete Newham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pete Newham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pete Newham more than expected).

Fields of papers citing papers by Pete Newham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pete Newham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pete Newham. The network helps show where Pete Newham may publish in the future.

Co-authorship network of co-authors of Pete Newham

This figure shows the co-authorship network connecting the top 25 collaborators of Pete Newham. A scholar is included among the top collaborators of Pete Newham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pete Newham. Pete Newham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Moreau, Kévin, Muireann Coen, Andrew X. Zhang, et al.. (2020). Proteolysis‐targeting chimeras in drug development: A safety perspective. British Journal of Pharmacology. 177(8). 1709–1718. 158 indexed citations

2.

Grant, Claire, Lorna Ewart, Daniel Muthas, et al.. (2016). The value of integrating pre-clinical data to predict nausea and vomiting risk in humans as illustrated by AZD3514, a novel androgen receptor modulator. Toxicology and Applied Pharmacology. 296. 10–18. 2 indexed citations

3.

Hattersley, Maureen M., et al.. (2014). Bromodomain and extraterminal (BET) domain inhibitors induce a loss of intestinal stem cells and villous atrophy. Toxicology Letters. 229. S75–S76. 4 indexed citations

4.

Hunter, David J., Gavin Bishop, Alexandra Davis, et al.. (2009). Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized. Arthritis Research & Therapy. 11(1). R11–R11. 173 indexed citations

5.

Hunter, David J., et al.. (2007). 12 BONE MARROW LESIONS FROM OSTEOARTHRITIS KNEES ARE CHARACTERIZED BY SCLEROTIC BONE THAT IS LESS WELL MINERALIZED. Osteoarthritis and Cartilage. 15. C21–C21. 1 indexed citations

6.

Hunter, David J., et al.. (2007). 308 ALTERED PERFUSION AND VENOUS HYPERTENSION IS PRESENT IN REGIONS OF BONE AFFECTED BY BMLS IN KNEE OA. Osteoarthritis and Cartilage. 15. C171–C172. 4 indexed citations

7.

Baxter, Andrew, Anne Cooper, Eike Floettmann, et al.. (2004). Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(11). 2817–2822. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact